Advertisement

Advertisement

2019 Transplantation and Cellular Therapy (TCT) Meetings

Hematologic Malignancies

By Caroline Helwick / May 25, 2019 / 2019 Transplantation and Cellular Therapy (TCT) Meetings

T-Cell Therapy for EBV-Associated Posttransplant Lymphoproliferative Disorder With CNS Involvement

An “off-the-shelf” allogeneic T-cell product, tabelecleucel, may effectively treat patients who develop Epstein-Barr virus (EBV)-associated posttransplant lymphoproliferative disorder with central ner...

Hematologic Malignancies

By Caroline Helwick / April 25, 2019 / 2019 Transplantation and Cellular Therapy (TCT) Meetings

PRIMeR Study Explores Meaning of Minimal Residual Disease in Myeloma

In a study that earned a Best Abstract Award at the 2019 Transplantation & Cellular Therapy (TCT) Meetings in Houston, minimal residual disease (MRD) negativity at 1 year after autologous hematopo...

Advertisement

Advertisement

Nov

24

Today In Oncology

Addition of Hyperthermic Intraperitoneal Chemotherapy to Surgery for Recurrent Ovarian Cancer

Penpulimab Combination Therapy for First-Line Treatment of Hepatocellular Carcinoma

Global Adaptive Platform Trial for Glioblastoma to Evaluate Novel ATM Kinase Inhibitor

Healthy Women May Have Aneuploid Epithelial Cells Resembling Breast Cancer

Perioperative Toripalimab in Locoregionally Advanced Nasopharyngeal Carcinoma

Advertisement

© 2024 HSP News Service, L.L.C.